Long-term Effects of Frequent Cannabis Use on Working Memory and Attention: an FMRI Study

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 2006 Mar 8

PMID 16521034

Citations 75

Authors

Gerry Jager

Rene S Kahn

Wim van den Brink

Jan M van Ree

Nick F Ramsey

Affiliations

Soon will be listed here.

Abstract

Rationale: Excessive use of cannabis may have long-term effects on cognitive abilities. Mild impairments have been found in several cognitive domains, particularly in memory and attention. It is not clear, however, whether these effects also occur with moderate, recreational use of cannabis. Furthermore, little is known about underlying brain correlates.

Objectives: The aim of this study is to assess brain function in frequent but relatively moderate cannabis users in the domains of working memory and selective attention.

Methods: Functional magnetic resonance imaging was used to examine verbal working memory and visuo-auditory selective attention in ten frequent cannabis users (after 1 week of abstinence) and ten non-using healthy controls. Groups were similar in age, gender and estimated IQ.

Results: Cannabis users and controls performed equally well during the working memory task and the selective attention task. Furthermore, cannabis users did not differ from controls in terms of overall patterns of brain activity in the regions involved in these cognitive functions. However, for working memory, a more specific region-of-interest analysis showed that, in comparison to the controls, cannabis users displayed a significant alteration in brain activity in the left superior parietal cortex.

Conclusion: No evidence was found for long-term deficits in working memory and selective attention in frequent cannabis users after 1 week of abstinence. Nonetheless, frequent cannabis use may affect brain function, as indicated by altered neurophysiological dynamics in the left superior parietal cortex during working memory processing.

Citing Articles

Brain Function Outcomes of Recent and Lifetime Cannabis Use.

Gowin J, Ellingson J, Karoly H, Manza P, Ross J, Sloan M JAMA Netw Open. 2025; 8(1):e2457069.

PMID: 39874032 PMC: 11775743. DOI: 10.1001/jamanetworkopen.2024.57069.

Chronic cannabis use differentially modulates neural oscillations serving the manipulate versus maintain components of working memory processing.

Huang P, Son J, Arif Y, John J, Horne L, Schantell M Neurobiol Dis. 2025; 205:106792.

PMID: 39765275 PMC: 11798582. DOI: 10.1016/j.nbd.2025.106792.

Biomarkers of cognitive and memory decline in psychotropic drug users.

Grigore M, Ruscu M, Hermann D, Colita I, Doeppner T, Glavan D J Neural Transm (Vienna). 2024; 132(1):39-59.

PMID: 39377784 PMC: 11735527. DOI: 10.1007/s00702-024-02837-4.

Review of the Use of Medicinal Cannabis Products in Palliative Care.

Troyer J, Tanco K Cancers (Basel). 2024; 16(7).

PMID: 38611090 PMC: 11011126. DOI: 10.3390/cancers16071412.

Does cannabis affect cognitive functioning in patients with schizophrenia?.

Rachid H, Saif Z, Raoui S, Serhier Z, Agoub M Schizophr Res Cogn. 2024; 36:100299.

PMID: 38196922 PMC: 10772380. DOI: 10.1016/j.scog.2023.100299.

References

Pope Jr H, Gruber A, Hudson J, Huestis M, Yurgelun-Todd D . Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry. 2001; 58(10):909-15. DOI: 10.1001/archpsyc.58.10.909. View

Eldreth D, Matochik J, Cadet J, Bolla K . Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. Neuroimage. 2004; 23(3):914-20. DOI: 10.1016/j.neuroimage.2004.07.032. View

Block R, Ghoneim M . Effects of chronic marijuana use on human cognition. Psychopharmacology (Berl). 1993; 110(1-2):219-28. DOI: 10.1007/BF02246977. View

Fan J, Posner M . Human attentional networks. Psychiatr Prax. 2004; 31 Suppl 2:S210-4. DOI: 10.1055/s-2004-828484. View

Grant I, Gonzalez R, Carey C, Natarajan L, Wolfson T . Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study. J Int Neuropsychol Soc. 2003; 9(5):679-89. DOI: 10.1017/S1355617703950016. View

Pope Jr H, Gruber A, Hudson J, Cohane G, Huestis M, Yurgelun-Todd D . Early-onset cannabis use and cognitive deficits: what is the nature of the association?. Drug Alcohol Depend. 2003; 69(3):303-10. DOI: 10.1016/s0376-8716(02)00334-4. View

Jacobsen L, Mencl W, Westerveld M, Pugh K . Impact of cannabis use on brain function in adolescents. Ann N Y Acad Sci. 2004; 1021:384-90. DOI: 10.1196/annals.1308.053. View

DEsposito M, Aguirre G, Zarahn E, Ballard D, Shin R, Lease J . Functional MRI studies of spatial and nonspatial working memory. Brain Res Cogn Brain Res. 1998; 7(1):1-13. DOI: 10.1016/s0926-6410(98)00004-4. View

Curran H, Brignell C, Fletcher S, Middleton P, Henry J . Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology (Berl). 2002; 164(1):61-70. DOI: 10.1007/s00213-002-1169-0. View

10.

Jansma J, Ramsey N, Slagter H, Kahn R . Functional anatomical correlates of controlled and automatic processing. J Cogn Neurosci. 2001; 13(6):730-43. DOI: 10.1162/08989290152541403. View

11.

Fletcher J, Page J, Francis D, Copeland K, Naus M, Davis C . Cognitive correlates of long-term cannabis use in Costa Rican men. Arch Gen Psychiatry. 1996; 53(11):1051-7. DOI: 10.1001/archpsyc.1996.01830110089011. View

12.

Collins D, Neelin P, Peters T, Evans A . Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr. 1994; 18(2):192-205. View

13.

de Win M, Jager G, Vervaeke H, Schilt T, Reneman L, Booij J . The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. Int J Methods Psychiatr Res. 2006; 14(4):167-85. PMC: 6878462. DOI: 10.1002/mpr.6. View

14.

Funahashi S . Neuronal mechanisms of executive control by the prefrontal cortex. Neurosci Res. 2001; 39(2):147-65. DOI: 10.1016/s0168-0102(00)00224-8. View

15.

Hall W, Christie M, Currow D . Cannabinoids and cancer: causation, remediation, and palliation. Lancet Oncol. 2005; 6(1):35-42. DOI: 10.1016/S1470-2045(04)01711-5. View

16.

Wood S . Evidence for using cannabis and cannabinoids to manage pain. Nurs Times. 2005; 100(49):38-40. View

17.

Callicott J, Bertolino A, Mattay V, Langheim F, Duyn J, Coppola R . Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex. 2000; 10(11):1078-92. DOI: 10.1093/cercor/10.11.1078. View

18.

Solowij N, Stephens R, Roffman R, Babor T, Kadden R, Miller M . Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA. 2002; 287(9):1123-31. DOI: 10.1001/jama.287.9.1123. View

19.

Ehrenreich H, Rinn T, Kunert H, Moeller M, Poser W, Schilling L . Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology (Berl). 1999; 142(3):295-301. DOI: 10.1007/s002130050892. View

20.

Pope Jr H, Gruber A, Yurgelun-Todd D . The residual neuropsychological effects of cannabis: the current status of research. Drug Alcohol Depend. 1995; 38(1):25-34. DOI: 10.1016/0376-8716(95)01097-i. View